![Matthew Lehman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Lehman
Amministratore Delegato presso
Koligo Therapeutics, Inc.
Profilo
Matthew B. Lehman is currently Chief Executive Officer at Koligo Therapeutics, Inc., and a member of the Association of Clinical Research Professionals and the European Business Association.
Formerly, Mr. Lehman was President, Chief Executive Officer & Director at Callitas Health, Inc. from 2015 to 2016; Chief Executive Officer, MD & Executive Director at Immutep Ltd. from 2013 to 2014; Chief Executive Officer & Executive Director at Koligo Therapeutics Ltd.; and Chief Operating Officer at SPRI Clinical Trials-Global LLC.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Louisville.
Posizioni attive di Matthew Lehman
| Società | Posizione | Inizio |
|---|---|---|
European Business Association | Corporate Officer/Principal | 03/01/2011 |
Association of Clinical Research Professionals
 Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Corporate Officer/Principal | 03/01/2011 |
Koligo Therapeutics, Inc.
 Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Amministratore Delegato | - |
Precedenti posizioni note di Matthew Lehman
| Società | Posizione | Fine |
|---|---|---|
Koligo Therapeutics Ltd.
 Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Amministratore Delegato | 18/02/2021 |
| CALLITAS HEALTH INC. | Amministratore Delegato | 15/03/2016 |
| IMMUTEP LIMITED | Amministratore Delegato | 09/07/2014 |
SPRI Clinical Trials-Global LLC
 SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Direttore operativo | - |
Formazione di Matthew Lehman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Callitas Health, Inc.
 Callitas Health, Inc. Pharmaceuticals: MajorHealth Technology Develops technologies for monitoring and treatment of obesity, diabetes & other gastroenterological indications | Health Technology |
SPRI Clinical Trials-Global LLC
SPRI Clinical Trials-Global LLC Miscellaneous Commercial ServicesCommercial Services Engages in clinical research | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immutep Ltd.
 Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
University of Louisville
 University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services Operates as a association of clinical research professionals | Commercial Services |
European Business Association | |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops, manufacture, and sells transformative cell therapies for the treatment of pancreatic diseases | Health Technology |
